Restructure Information

On March 15, 2021, Purdue Pharma L.P. submitted a Plan of Reorganization to the Bankruptcy Court.
The Plan charts a path for more than $10 billion of value, including 100% of Purdue’s assets and millions of doses of opioid addiction treatment and overdose reversal medicines, to be delivered to claimants and communities across the country affected by the opioid crisis.

Read our statement Speaking Out Against Systemic Racism here


FDA Accepts Filing of Abbreviated New Drug Application and Grants Priority Review for Nalmefene HCI Injection for the Treatment of Known or Suspected Opioid Overdose

Stamford, Conn., June 10, 2021 – Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application for the vial dosage form…

Purdue Pharma L.P. to Begin Soliciting Votes for its Broadly Supported Chapter 11 Plan of Reorganization

STAMFORD, Conn. – [May 3, 2021] – Purdue Pharma L.P. today announced that the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) has approved, among other…

Purdue Pharma L.P. Files Broadly Supported Plan of Reorganization

Plan will create National Opioid Abatement Trust Plan will make more than $10 billion in value available for opioid abatement programs across the country 100% of Purdue’s assets will be transferred…

Opinion – Steve Miller: Purdue bankruptcy presents historic opportunity to fund opioid abatement efforts; USA Today

March 23, 2021

Approval of Purdue’s plan would mark a milestone moment for the public health in our country because it has been structured to guarantee that billions of dollars will go to opioid abatement efforts.


Engaging Our Communities to Save Lives – Quickly

In an emergency, every second counts. But sometimes there aren’t enough seconds to get to the emergency on time. And, in some communities and countries, there is no emergency response system at all. That’s why Jason Friesen, Founder and Executive Director of Trek Medics, put technology to work to save lives.


Bringing “Hope & Healing to Those Affected by Opioids”

Providence Regional Medical Center Everett (PRMCE) is a full-service medical center offering cardiology, cancer treatment, neuroscience, a birthing center and a Level 2 Trauma Center serving patients from several counties in Washington. It’s the access to so many patients with opioid dependence that inspired emergency physician Thomas E. Robey, MD, PhD, to work toward improved treatment options for people suffering from substance use disorder (SUD).


Progress Over Perfection: The Secret to Success at the Children’s Center of Hamden

When it comes to teens navigating the issue of substance use and substance use disorder, The Children’s Center of Hamden in Connecticut knows that prioritizing realistic progress, offering teens alternatives, and providing the support to seek treatment services – on their own terms – makes all the difference.

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parities’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.